Pancragen 20 mg

Pancragen is a synthetic bioactive tetrapeptide bioregulator composed of a specific amino acid sequence associated with pancreatic cellular regulation. It is studied for its role in supporting pancreatic cell activity, maintaining endocrine balance, and modulating age-related functional decline in pancreatic tissue.

Research interest in Pancragen has focused on pancreatic cell differentiation, glucose metabolism regulation, endocrine signaling pathways, and cellular repair mechanisms in pancreatic research models. Additional investigations explore its relevance in metabolic balance, inflammatory modulation, and pancreatic tissue maintenance.

(Khavinson et al., 2013 — Advances in Gerontology).

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

Pancragen Overview

Pancragen is a low–molecular weight regulatory peptide designed to influence intracellular signaling pathways involved in pancreatic structure and function. Due to its compact tetrapeptide structure, it is studied as a signaling modulator rather than a direct pharmaceutical agent.

Unlike conventional metabolic regulators, Pancragen is investigated for its ability to support coordinated pancreatic activity, including both exocrine and endocrine functions, making it a valuable research compound for studying pancreatic homeostasis and age-related metabolic changes.